AACR Statement on the Russian Invasion of Ukraine and the Threat to Cancer Patients and Research
Today, AACR President David A. Tuveson, MD, PhD, FAACR, and AACR Chief Executive Officer Margaret Foti, PhD, MD (hc),...
Today, AACR President David A. Tuveson, MD, PhD, FAACR, and AACR Chief Executive Officer Margaret Foti, PhD, MD (hc),...
PHILADELPHIA – T-cell responses directed against the receptor-binding domain of the SARS-CoV-2 spike protein were associated with protection from...
PHILADELPHIA – A new mutation was identified in 9 percent of relapsed cases of pediatric acute myeloid leukemia (AML)...
AACR expresses appreciation to Janet Woodcock, MD, for her excellent stewardship as FDA’s Acting Commissioner PHILADELPHIA — The American...
PHILADELPHIA – The American Association for Cancer Research (AACR) today congratulated Raymond N. DuBois, MD, PhD, FAACR, on his...
PHILADELPHIA – Today, the American Association for Cancer Research (AACR) released the AACR Report on the Impact of COVID-19...
WASHINGTON, DC – Today, American Association for Cancer Research (AACR) CEO Margaret Foti, PhD, MD (hc), issued the following...
PHILADELPHIA – Compared to U.S. urban adults, rural adults were more likely to think fatalistically about cancer and feel...
Risk may be greatest among young Black and Hispanic subgroups PHILADELPHIA – Individuals between 20 and 39 years old...
Findings have implications for future cancer clinical trial design involving immune checkpoint inhibitors PHILADELPHIA – Independent drug action, not...